Douglas B Cines

Title: The Innovative Journey of Douglas B. Cines in Medical Patents

Introduction

Douglas B. Cines, a prominent inventor based in Wynnewood, Pennsylvania, has made significant contributions to the medical field, particularly in the realm of hematology. With a robust portfolio comprising 18 patents, his innovative work primarily focuses on treatments for conditions associated with heparin-induced thrombocytopenia (HIT), a serious complication arising from the use of heparin.

Latest Patents

Cines's recent patents are at the forefront of medical research. One notable invention includes "Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia." This invention provides isolated antibodies or antibody fragments that specifically bind to platelet factor 4 (PF4). The patent outlines methods for treating HIT and reducing the likelihood of its occurrence, highlighting the potential for clinical applications of these antibodies in patient treatment.

Another significant patent is the "Atomic description of immune complex that causes heparin-induced thrombocytopenia." This invention introduces a mutant protein that retains the amino acid sequence of wild type PF4, with modifications aimed at enhancing its therapeutic potential. The patent discusses methods of treating HIT and other related coagulation pathologies by administering these mutant proteins to patients.

Career Highlights

Cines's illustrious career includes associations with distinguished institutions such as the University of Pennsylvania and the University of Virginia. His work at these universities has facilitated groundbreaking research and development in the medical field, bolstering the understanding and treatment of coagulation disorders.

Collaborations

Throughout his career, Cines has collaborated with esteemed colleagues, including Abd Al-Roof Higazi and Mark I. Greene. These collaborations have played a vital role in advancing their collective research and patent applications, further underscoring the impact of teamwork in the innovation process.

Conclusion

Douglas B. Cines stands out as a trailblazer in the field of medical innovation. His patents not only contribute to the scientific community's understanding of heparin-induced thrombocytopenia but also pave the way for new treatment options that can significantly improve patient outcomes. The ongoing importance of his work underscores the vital role of inventors in advancing medical science and technology.